It is interesting that heterozygous mutations in other genes in this pathway (i.e., BRCA1, BRCA2, CHEK2, NBN, ATM) predispose to breast cancer, but a heterozygous mutation in BLM does not appear to be pathogenic for breast cancer. Here, ATM is linked to breast carcinoma.